Cambridge Investment Research Advisors, Inc. Novartis Ag Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 52,862 shares of NVS stock, worth $6.97 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
52,862
Previous 58,465
9.58%
Holding current value
$6.97 Million
Previous $6.52 Million
1.86%
% of portfolio
0.02%
Previous 0.02%
Shares
34 transactions
Others Institutions Holding NVS
# of Institutions
1,563Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.4 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.37 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.19 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$996 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$939 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $283B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...